Novel Treatments for Neuromuscular Disorders


Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for muscle cramps, spasms and spasticity associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 


August 1, 2018 Flex Pharma Reports Second Quarter 2018 Financial Results
Read More

June 13, 2018 Flex Pharma Announces Corporate Update
Read More